EN | TR
E-ISSN: 3061-9947
Quality of Life Assessment with EORTC QLQ in Patients with Hodgkin Lymphoma: Multicenter Study
PDF
Cite
Share
Request
Original Article
VOLUME: 55 ISSUE: 2
P: 128-138
2022

Quality of Life Assessment with EORTC QLQ in Patients with Hodgkin Lymphoma: Multicenter Study

Acta Haematol Oncol Turc 2022;55(2):128-138
DOI: 10.5505/aot.2022.25991
Aliihsan Gemici 1
Istemi Serin 2
Vedat Buğra Erol 3
Mehmet Hilmi Doğu 4
İdris İnce 5
Rafet Eren 6
Atakan Tekinalp 7
Volkan Karakuş 8
Ömur Gökmen Sevindik 1
1. Istanbul Medipol University, Department of Hematology, Istanbul, TURKEY
2. University of Health Sciences, Istanbul Training and Research Hospital, Department of Hematology, Istanbul, TURKEY
3. Istanbul Medipol University, Department of Internal Medicine, Istanbul, TURKEY
4. Istinye University, Department of Internal Medicine and Hematology, Liv Hospital Ulus, Istanbul, TURKEY
5. University of Health Sciences, Dr. Ersin Arslan Training and Research Hospital, Gaziantep, TURKEY
6. Istinye University, Department of Internal Medicine and Hematology, Istanbul, TURKEY
7. Necmettin Erbakan University, Department of Hematology, Konya, TURKEY
8. Alaattin Keykubat University, Department of Hematology, Alanya, TURKEY
9.
No information available.
No information available
Received Date: 2021-08-29T20:30:14
Accepted Date: 2022-08-01T05:56:03
PDF
Cite
Share
Request

Abstract

INTRODUCTION

The aim of our study is to obtain data on the quality of life (QoL) in Hodgkin lymphoma (HL) patients in a representative sample of the general population of Turkey with the help of the EORTC QLQ-C30 and QLQ-HL27 questionnaires.

METHODS

A total of 68 patients from 7 different centers diagnosed with HL between 2018-2020 were included in the study. The questionnaires were answered cross-sectionally by the patient under the control of a physician in the centers participating in the study.

RESULTS

Out of 68 patients, 42.6% (n=29) were female and 57.4% (n=39) were male. The ages of the patients ranged from 18 to 74 years, with a mean of 42.10±16.62 and with a median value of 40 years. There was no significant difference between age subgroups in terms of QLQ-C30 global health status/ QoL, functional or symptom scales and HL27 SB, PC, EI and WF scores (p>0.05, for all). It was determined that the constipation scores of females were higher than the scores of males (p=0.041). No statistically significant difference was found in terms of HL27 SB, PC, EI and WF sub-dimension scores according to gender (p>0.05).

DISCUSSION AND CONCLUSION

There was only a statistically significant difference in terms of QLQ-C30 constipation sub-dimension scores according to gender. The constipation scores of females were higher than the scores of men. More detailed and large population studies are needed to reveal the effectiveness of QoL assessment in HL patients.